Skip to main content

Blog

Join our 2023 Coach to Cure MD team!

...

Duchenne Newborn Screening milestone—first state with universal newborn screening for Duchenne!

...

Catch up on what’s happening at PPMD’s 2023 Annual Conference: Day 3

...

Catch Up on What’s Happening at PPMD’s 2023 Annual Conference: Day 2

...

Catch Up on What’s Happening at PPMD’s 2023 Annual Conference: Day 1

...

Italfarmaco Group Announces NDA Accepted for Givinostat

...

Edgewise Therapeutics announces positive topline 12-month data from EDG-5506 ARCH study

...

FDA grants approval via accelerated approval pathway to ELEVIDYS: First-ever gene therapy for individuals with Duchenne ages 4-5

...

Santhera announces exclusive North America license agreement with Catalyst Pharmaceuticals for vamorolone

...

Thanks to you PPMD continues forward in all areas of support

...